A first-in-human study of AMG 208, an oral MET inhibitor, in adult patients with advanced solid tumors
about
Preclinical and clinical evaluation of MET functions in cancer cells and in the tumor stroma.Investigational drugs for head and neck cancer.The Therapeutic Potential of Targeting the HGF/cMET Axis in Ovarian Cancer.An Assessment of Early Response to Targeted Therapy via Molecular Imaging: A Pilot Study of 3'-deoxy-3'[(18)F]-Fluorothymidine Positron Emission Tomography 18F-FLT PET/CT in Prostate Adenocarcinoma.
P2860
A first-in-human study of AMG 208, an oral MET inhibitor, in adult patients with advanced solid tumors
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
A first-in-human study of AMG ...... nts with advanced solid tumors
@ast
A first-in-human study of AMG ...... nts with advanced solid tumors
@en
type
label
A first-in-human study of AMG ...... nts with advanced solid tumors
@ast
A first-in-human study of AMG ...... nts with advanced solid tumors
@en
prefLabel
A first-in-human study of AMG ...... nts with advanced solid tumors
@ast
A first-in-human study of AMG ...... nts with advanced solid tumors
@en
P2093
P2860
P50
P356
P1433
P1476
A first-in-human study of AMG ...... nts with advanced solid tumors
@en
P2093
A Craig Lockhart
Benny Amore
Darrin M Beaupre
David S Hong
Gataree Ngarmchamnanrith
Hongjie Deng
Isaac Caudillo
Peter Rosen
Rabia Khan
P2860
P304
18693-18706
P356
10.18632/ONCOTARGET.4472
P407
P577
2015-06-19T00:00:00Z